96-25258. Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers  

  • [Federal Register Volume 61, Number 193 (Thursday, October 3, 1996)]
    [Rules and Regulations]
    [Pages 51587-51588]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-25258]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    21 CFR Part 178
    
    [Docket No. 95F-0175]
    
    
    Indirect Food Additives: Adjuvants, Production Aids, and 
    Sanitizers
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the food 
    additive regulations to expand the safe use of sodium 2,2'-methylenebis 
    (4,6-di-tert-butylphenyl) phosphate as a clarifying agent in 
    polypropylene articles intended for contact with food. This action is 
    in response to a petition filed by Asahi Denka Kogyo K.K.
    
    DATES: Effective October 3, 1996; written objections and requests for a 
    hearing by November 4, 1996.
    
    ADDRESSES: Submit written objections to the Dockets Management Branch 
    (HFA-305), Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23, 
    Rockville, MD 20857.
    
    FOR FURTHER INFORMATION CONTACT: John R. Bryce, Center for Food Safety 
    and Applied Nutrition (HFS-216), Food and Drug Administration, 200 C 
    St. SW., Washington, DC 20204, 202-418-3023.
    
    SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
    Register of July 13, 1995 (60 FR 36149), FDA announced that a food 
    additive petition (FAP 5B4458) had been filed by Asahi Denka Kogyo 
    K.K., c/o Japan Technical Information Center, Inc., 775 South 23d St., 
    Arlington, VA 22202. The petition proposed to amend Sec. 178.3295 
    Clarifying agents for polymers (21 CFR 178.3295) of the food additive 
    regulations to provide for the safe use of sodium 2,2'-methylenebis 
    (4,6-di-tert-butylphenyl) phosphate as a clarifying agent in 
    polypropylene articles intended for contact with food under conditions 
    of use A and B as described in Table 2 of 21 CFR 176.170(c).
        FDA has evaluated data in the petition and other relevant material. 
    Based on this information, the agency concludes that the proposed use 
    of the additive is safe, and the additive will achieve its intended 
    technical effect; therefore the regulations in Sec. 178.3295 should be 
    amended as set forth below.
        FDA's review of the subject petition indicates that the additive 
    may contain trace amounts of formaldehyde as an impurity. The potential 
    carcinogenicity of formaldehyde was reviewed by the Cancer Assessment 
    Committee (the Committee) of FDA's Center for Food Safety and Applied 
    Nutrition. The Committee noted that for many years formaldehyde has 
    been known to be a carcinogen by the inhalation route, but it concluded 
    that these inhalation studies are not appropriate for assessing the 
    potential carcinogenicity of formaldehyde in food. The Committee's 
    conclusion was based on the fact that the route of administration 
    (inhalation) is not relevant to the safety of formaldehyde residues in 
    food and the fact that tumors were observed only locally at the portal 
    of entry (nasal turbinates). In addition, the agency has received 
    literature reports of two drinking water studies on formaldehyde: (1) A 
    preliminary report of a carcinogenicity study purported to be positive 
    by Soffritti et al. (1989), conducted in Bologna, Italy (Ref. 1); and 
    (2) a negative study by Til, et al. (1989), conducted in The 
    Netherlands (Ref. 2). The Committee reviewed both studies and 
    concluded, concerning the Soffritti study,
    ``* * * that the data reported were unreliable and could not be used in 
    the assessment of the oral carcinogenicity of formaldehyde'' (Ref. 3). 
    This conclusion is based on a lack of critical detail in the study, 
    questionable histopathologic conclusions, and the use of unusual 
    nomenclature to describe the tumors. Based on the Committee's 
    evaluation, the agency has determined that there is no basis to 
    conclude that formaldehyde is a carcinogen when ingested.
        In accordance with Sec. 171.1(h) (21 CFR 171.1(h)), the petition 
    and the documents that FDA considered and relied upon in reaching its 
    decision to approve the petition are available for inspection at the 
    Center for Food Safety and Applied Nutrition by appointment with the 
    information contact person listed above. As provided in Sec. 171.1(h), 
    the agency will delete from the documents any materials that are not 
    available for public disclosure before making the documents available 
    for inspection.
        The agency has carefully considered the potential environmental 
    effects of this action. FDA has concluded that the action will not have 
    a significant impact on the human environment, and that an 
    environmental impact statement is not required. The agency's finding of 
    no significant impact and the evidence supporting that finding, 
    contained in an environmental assessment, may be seen in the Dockets 
    Management Branch (address above) between 9 a.m. and 4 p.m., Monday 
    through Friday.
        Any person who will be adversely affected by this regulation may at 
    any time on or before November 4, 1996, file with the Dockets 
    Management Branch (address above) written objections thereto. Each 
    objection shall be separately numbered, and each numbered objection 
    shall specify with particularity the provisions of the regulation to 
    which objection is made and the grounds for the objection. Each 
    numbered objection on which a hearing is requested shall specifically 
    so state. Failure to request a hearing for any particular objection 
    shall constitute a waiver of the right to a hearing on that objection. 
    Each numbered objection for which a hearing is requested shall include 
    a detailed description and analysis of the specific factual information 
    intended to be presented in support of the objection in the event that 
    a hearing is held. Failure to include such a description and analysis 
    for any particular objection shall constitute a waiver of the right to 
    a hearing on the objection. Three copies of all documents shall be 
    submitted and shall be identified with the docket number found in 
    brackets in the heading of this document. Any objections received in 
    response to the regulation may be seen in the Dockets Management Branch 
    between 9 a.m. and 4 p.m., Monday through Friday.
    
    References
    
        The following references have been placed on display in the Dockets 
    Management Branch (address above) and may be seen by interested persons 
    between 9 a.m. and 4 p.m., Monday through Friday.
        1. Soffritti, M., C. Maltoni, F. Maffei, and R. Biagi, 
    ``Formaldehyde: An Experimental Multipotential Carcinogen,'' 
    Toxicology and Industrial Health, Vol. 5, No. 5:699-730, 1989.
        2. Til, H. P., R. A. Woutersen, V. J. Feron, V. H. M. 
    Hollanders, H. E. Falke, and J. J. Clary, ``Two-Year Drinking Water 
    Study of Formaldehyde in Rats,'' Food Chemical Toxicology, Vol. 27, 
    No. 2, pp. 77-87, 1989.
        3. Memorandum of Conference concerning ``Formaldehyde,'' Meeting 
    of the Cancer Assessment Committee, FDA, April 24, 1991, and March 
    4, 1993.
    
    List of Subjects in 21 CFR Part 178
    
        Food additives, Food packaging.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    178 is amended as follows:
    
    [[Page 51588]]
    
    PART 178--INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND 
    SANITIZERS
    
        1. The authority citation for 21 CFR part 178 continues to read as 
    follows:
    
        Authority: Secs. 201, 402, 409, 721 of the Federal Food, Drug, 
    and Cosmetic Act (21 U.S.C. 321, 342, 348, 379e).
    
        2. Section 178.3295 is amended in the table by revising the entry 
    for ``Sodium 2,2'-methylenebis (4,6-di-tert-butylphenyl) phosphate'' to 
    read as follows:
    
    
    Sec. 178.3295  Clarifying agents for polymers.
    
    * * * * *
    
                                                                                                                    
    ----------------------------------------------------------------------------------------------------------------
                           Substances                                              Limitations                      
    ----------------------------------------------------------------------------------------------------------------
      *                    *                    *                    *                    *                    *    
                                                                 *                                                  
    Sodium 2,2'-methylenebis (4,6-di-tert-butylphenyl)       For use only:                                          
     phosphate (CAS Reg. No. 85209-91-2).                                                                           
                                                             1. As a clarifying agent at a level not exceeding 0.30 
                                                              percent by weight of olefin polymers complying with   
                                                              Sec.  177.1520(c) of this chapter, items 1.1, 3.1, or 
                                                              3.2 (where the copolymers complying with items 3.1 and
                                                              3.2 contain not less than 85 weight percent of polymer
                                                              units derived from polypropylene). The finished       
                                                              polymers contact foods only of types I, II, IV-B, VI- 
                                                              B, VII-B, and VIII as identified in Table 1 of Sec.   
                                                              176.170(c) of this chapter and limited to conditions  
                                                              of use B through H, described in Table 2 of Sec.      
                                                              176.170(c), or foods of all types, limited to         
                                                              conditions of use C through H described in Table 2 of 
                                                              Sec.  176.170(c).                                     
                                                             2. As a clarifying agent at a level not exceeding 0.10 
                                                              percent by weight of polypropylene complying with Sec.
                                                               177.1520(c) of this chapter, item 1.1. The finished  
                                                              polypropylene may be used in contact with foods of all
                                                              types under conditions of use A through H described in
                                                              Table 2 of Sec.  176.170(c) of this chapter.          
    ----------------------------------------------------------------------------------------------------------------
    
    
        Dated: September 26, 1996.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 96-25258 Filed 10-2-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
10/3/1996
Published:
10/03/1996
Department:
Health and Human Services Department
Entry Type:
Rule
Action:
Final rule.
Document Number:
96-25258
Dates:
Effective October 3, 1996; written objections and requests for a hearing by November 4, 1996.
Pages:
51587-51588 (2 pages)
Docket Numbers:
Docket No. 95F-0175
PDF File:
96-25258.pdf
CFR: (3)
21 CFR 177.1520(c)
21 CFR 176.170(c)
21 CFR 178.3295